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Castillo AB, Triplett JW, Pavalko FM, Turner CH. Estrogen
receptor- regulates mechanical signaling in primary osteoblasts. Am
J Physiol Endocrinol Metab 306: E937–E944, 2014. First published
March 11, 2014; doi:10.1152/ajpendo.00458.2013.—Mechanical
loading is an important regulator in skeletal growth, maintenance, and
aging. Estrogen receptors have a regulatory role in mechanically
induced bone adaptation. Estrogen receptor- (ER) is known to
enhance load-induced bone formation, whereas ER negatively reg-
ulates this process. We hypothesized that ER regulates mechanical
signaling in osteoblasts. We tested this hypothesis by subjecting
primary calvarial cells isolated from wild-type and ER-knockout
mice (BERKO) to oscillatory fluid flow in the absence or presence of
estradiol (E2). We found that the known responses to fluid shear
stress, i.e., phosphorylation of the mitogen-activated protein kinase
ERK and upregulation of COX-2 expression, were inhibited in
BERKO cells in the absence of E2. Flow-induced increase in prosta-
glandin E2 (PGE2) release was not altered in BERKO cells in the
absence of E2, but was increased when E2 was present. Additionally,
immunofluorescence analysis and estrogen response element lu-
ciferase assays revealed increased ER expression and flow- and
ligand-induced nuclear translocation as well as transcriptional activity
in BERKO cells in both the presence and absence of E2. Taken
together, these data suggest that ER plays both ligand-dependent and
ligand-independent roles in mechanical signaling in osteoblasts. Fur-
thermore, our data suggest that one mechanism by which ER
regulates mechanotransduction in osteoblasts may result from its
inhibitory effect on ER expression and function. Targeting estrogen
receptors (e.g., inhibiting ER) may represent an effective approach
for prevention and treatment of age-related bone loss.
estrogen receptor-; osteoblast; mechanobiology; cyclooxygenase-2;
prostaglandin E2
MECHANICAL LOADING IS AN IMPORTANT REGULATOR in skeletal
growth, maintenance, and aging (25, 41, 47). Increased bone
formation is observed typically with increased mechanical
loading, whereas bone loss is observed with decreased me-
chanical loading or disuse (27, 48). Current evidence suggests
that mechanical stress is sensed by osteocytes, which then
signal osteoblasts and osteoclasts to either add or remove bone,
respectively (5). The mechanism by which a physical stimulus
is transformed into a biochemical signal, termed mechano-
transduction, remains unclear (6).
Estrogen is a key regulator of bone formation. During
growth, radial expansion of long bones occurs at similar rates
in boys and girls. However, at the onset of puberty, when
estrogen levels increase in girls, periosteal expansion is inhib-
ited (44). Conversely, at the onset of menopause, when estro-
gen levels fall in women, radial expansion recommences,
suggesting that estrogen inhibits periosteal bone apposition
(19). Estrogen also appears to inhibit exercise-induced perios-
teal expansion (4, 25).
The mechanism for opposing effects of estrogen on bone
formation appears to be related to signaling through distinct
receptor isoforms. Estrogen signals via two receptors, estrogen
receptor (ER) and ER, which are members of the superfam-
ily of ligand-regulated nuclear receptors (20). The amino acid
sequence homology between the two receptors is 97% in the
DNA-binding domain and 56% in the ligand-binding do-
main. Ligand binding induces a conformational change, recep-
tor dimerization, and translocation to the nucleus, where the
activated receptor complex binds to DNA and recruits coregu-
lator proteins to affect gene transcription. ERs can activate
transcription by binding directly to DNA at the classical
estrogen response element (ERE) or indirectly through inter-
actions with the Jun/Fos family of transcription factors, which
bind at activator protein-1 (AP-1) genomic elements (26).
Transcriptional activity of ER and ER is mediated by two
transcription activation functions (AF), AF-1 and AF-2, that
can exhibit differential activity levels, depending on the ligand,
receptor type, and enhancer element combination (37). ER
has been shown to reverse or inhibit ER activation at AP-1
sites, suggesting that ER has an overall suppressive action on
transcription of certain genes modulated by ER (30).
ER and ER are expressed in human, rat, and mouse
osteoblasts and osteocytes (8, 36). Damien et al. (12) showed
that a selective estrogen receptor modulator and ICI-182,780, a
pure ER antagonist, inhibit the proliferative response of osteo-
blasts to strain and estrogen. In addition, they showed that
mechanical strain results in the phosphorylation of ER, which
is dependent on the phosphorylation of extracellular signal-
regulated kinase (ERK), a member of the mitogen-activated
protein kinase (MAPK) family that is important in cell prolif-
eration, differentiation, and apoptosis (21). Both strain and
estrogen result in a pronounced translocation of ER from the
cytoplasm to the nucleus in osteoblasts and osteocytes (56). In
addition, both strain and estrogen result in an increase in ER
transcriptional activity, as measured by an ERE luciferase
activity assay (55), providing further evidence for a role for
ERs in mechanical signaling in osteoblasts.
The specific role of each ER isoform in mechanically in-
duced bone adaptation has been implicated in studies using
ER-knockout mice. Lee et al. (28) showed that strain-induced
periosteal bone formation was almost completely absent in
ER-knockout (ERKO) mice. Conversely, similar studies in
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female ER knockout (BERKO) mice exhibited an enhanced
load-induced response suggesting that signaling via ER nor-
mally suppresses periosteal bone formation (42, 43). These
findings were supported by in vitro studies in which primary
long bone osteoblasts isolated from ERKO mice exhibited no
strain-related increase in proliferation, whereas osteoblasts
isolated from BERKO mice exhibited a 125% increase in cell
number following mechanical strain (29). Finally, Galea et al.
(18) has provided evidence that both strain and estrogen work
through ER to downregulate Sost expression, which in turn
enhances osteogenic activity (49a). Taken together, these data
suggest that both ER and ER can regulate mechanical
signaling in bone and influence bone adaptation and that the
ER itself or signaling via ERmay normally oppose mechan-
ical signaling via ER in osteoblasts.
The aim of this work was to further elucidate mechanisms by
which ER regulates osteoblast function in response to me-
chanical stimulation. We isolated primary calvarial cells from
wild-type (WT) and BERKO neonates and subjected them to
oscillatory fluid flow (OFF) for varying periods in the absence
and presence of estradiol (E2) and evaluated ERK, cyclooxy-
genase-2 (COX-2), and prostaglandin (PGE2) signaling as well
as expression of receptor levels and ER transcriptional activity.
MATERIALS AND METHODS
Cell culture. All experimental procedures involving primary mouse
osteoblasts were approved by the Indiana University School of Med-
icine Institutional Animal Care and Use Committee. Primary mouse
calvarial cells were isolated as described previously (54). Briefly,
calvaria from 3- to 5-day-old WT and BERKO mice (14) were
isolated aseptically and exposed to seven consecutive 10-min diges-
tions in 0.2% collagenase-0.25% trypsin. Cells released in the second
through seventh digestions were pooled and maintained in phenol
red-free Dulbecco’s minimum essential medium (DMEM) supple-
mented with 10% fetal calf serum (FCS), 4 mM L-glutamine, and 1%
penicillin-streptomycin antibiotics (Gibco-Invitrogen, Carlsbad, CA).
At 80–90% confluence, cells were passaged by brief trypsinization,
with the medium changed every day. The osteoblastic phenotype was
confirmed by treatment with ascorbic acid (50 g/ml), resulting in
positive staining for alkaline phosphatase expression (data not
shown). For all experiments passages 4–6 were used, and cells were
in a proliferative, nondifferentiated stage of growth.
OFF. All fluid flow experiments were performed under sterile
conditions. Primary calvarial osteoblasts from WT and BERKO neo-
nates were plated at 2,500/cm2 onto glass slides coated with rat type
I collagen and grown to 80% confluence. Twenty-four hours before
flow, cells were cultured in serum-free medium (phenol red-free
DMEM  0% FCS  4 mM L-glutamine  1% penicillin-strepto-
mycin) with ICI-182 780 (106 M), a pure ER antagonist (Sigma
Aldrich, St. Louis, MO), when appropriate. On the day of flow, slides
were maintained in static culture or loaded individually into parallel
plate flow chambers (17) containing E2-free or E2-supplemented
(107 M) flow medium. Chambers were connected in series to
rigid-walled tubing and a Hamilton glass syringe and plunger. The
plunger was driven by a custom-built oscillatory loading device,
which produced fluid-flow shear stress (15 dyn/cm2, 1 Hz). Depend-
ing on the outcome measurement, varying flow periods were used. For
p-ERK analysis, 30-min flows were performed. For PGE2 release and
COX-2 expression, 4-h flows were performed, followed by a 1-h
postflow incubation. For ER nuclear translocation, 1-h flows were
performed. For ERE luciferase activity, 12-h flows were performed.
Immunoblot analysis. For immunoblot analysis, cells were col-
lected in SDS-PAGE sample buffer, and protein concentration was
determined using an amido black assay (45). Equal protein (20 g)
was separated by SDS-PAGE and transferred to nitrocellulose for
immunoblotting. The following primary antibodies were used: rabbit
polyclonal anti-ERK1 and -2 (Santa Cruz Biotechnology, Santa Cruz,
CA), mouse monoclonal anti-phospho-ERK (Santa Cruz Biotechnol-
ogy), rabbit polyclonal anti-COX-2 (Cayman Chemical, Ann Arbor,
MI), mouse monoclonal anti-actin (Sigma-Aldrich, St. Louis, MO),
and mouse monoclonal anti-vinculin (Sigma-Aldrich). Appropriate
anti-mouse or anti-rabbit horseradish peroxidase-conjugated second-
ary antibodies (Jackson ImmunoResearch Laboratories, West Grove,
PA) were used. Horseradish peroxidase chemiluminescence was de-
tected using a Fujifilm LAS-3000 image detection system (Fujifilm,
Tokyo, Japan), and densitometric analysis was performed using Fu-
jifilm MultiGauge (version 2) densitometric analysis software (Fujif-
ilm). Actin or vinculin expression was used to normalize gene ex-
pression. A minimum of three samples per experimental group was
quantified.
PGE2 release. For assessment of prostaglandin release in response
to fluid shear stress, cells were subjected to either static conditions or
OFF for 4 h. After flow, slides were overlaid with 1 ml pf flow
medium and placed in the incubator for 1 h. After 1 h, the medium
was collected and assessed for PGE2 concentration using an enzyme
immunoassay per the manufacturer’s instructions (Amersham Biosci-
ences, Piscataway, NJ). Results were normalized to total cellular
protein, as determined by an amido black assay. A minimum of four
samples per experimental group was quantified.
Immunofluorescence analysis. WT and BERKO primary calvarial
cells were subjected to static conditions or OFF for 1 h, and cells were
fixed in cold 4% paraformaldehyde and permeabilized in 0.2% Triton
in PBS. A primary antibody against ER (Affinity Bioreagents,
Golden, CO) and a FITC-conjugated secondary antibody (Jackson
ImmunoResearch Laboratories) were used to visualize ER, and
DAPI stain (Sigma Chemical, St. Louis, MO) was used to visualize
nuclei. Images were captured using a SPOT RT digital camera
(Diagnostic Instruments) attached to an Optiphot-2 Nikon epifluores-
cent microscope with a PlanApo40 Nikon objective (Nikon, Tokyo,
Japan). At least three separate flow experiments were performed for
each group, and10 fields per experiment (slide) were captured. ER
expression in WT and BERKO cells was quantified by digital image
analysis (Image J; National Institutes of Health) using a threshold
technique that captured the number of pixels representing fluorescing
protein with each cell.
ERE luciferase reporter. An ERE luciferase reporter plasmid (0.5
g; Panomics) together with an internal control thymidine kinase-
driven Renilla luciferase vector plasmid (pRL-TK, 0.5 g; kindly
provided by Dr. B. Paul Herring) were cotransfected into WT and
BERKO cells. Cells were plated onto glass slides at 50% confluence.
The following day, cells were incubated with a total of 1 g of
plasmid DNA and 2 l of FuGENE 6 transfection reagent (Roche
Diagnostics) in 100 l of phenol red-free, additive-free DMEM
(Gibco-Invitrogen). At 48 h posttransfection, cells were subjected to
either static conditions or OFF for 12 h. We chose the 12-h time point
because 12-h E2 treatment was shown to induce a detectable increase
(2.5-fold) in relative luciferase activity (firefly/Renilla) in WT cells
overexpressing ER (data not shown). After flow, cell lysates were
collected. Reporter gene firefly luciferase activities were normalized
to internal control Renilla luciferase activities using a Dual Luciferase
Reporter Assay System (Promega, Madison, WI) according to the
manufacturer’s instructions. Data are presented as normalized
relative light units. A minimum of three samples per experimental
group were analyzed.
Data analysis. Differences were tested for significance using a
three-factor ANOVA, with genotype, OFF, and E2 treatment serving
as main factors. Statistical significance was assumed for P 	 0.05.
Data are presented as means 
 SE.
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RESULTS
BERKO calvarial cells exhibit reduced OFF-induced ERK
phosphorylation, which is restored by E2 treatment. To deter-
mine the role of ER in mechanical signaling in osteoblasts,
primary calvarial cells were subjected to 30 min of OFF in the
absence and presence of E2. Phosphorylation of ERK, a well-
known reaction to fluid flow, was determined. In the absence of
E2, WT cells (WT  VEH) subjected to OFF exhibited an
approximately fourfold significant increase in ERK phosphor-
ylation normalized by ERK compared with static controls
(Fig. 1). Under the same conditions, BERKO cells exhibited an
increase of approximately twofold, only half of that observed in
WTVEH cells. The absolute value of p-ERK/ERK in BERKO
VEH exposed to OFF was approximately twofold lower than
that observed in WT  VEH flowed cells. Interestingly, in the
presence of E2, flow-induced ERK phosphorylation was re-
stored to near-control levels in BERKO cells, although the
difference between groups did not reach significance.
Flow-induced COX-2 upregulation in BERKO cells in the
absence of E2 is attenuated but restored in the presence of E2.
Upregulation of COX-2 protein, the rate-limiting enzyme in
the production of PGE2 and an important mediator of in vivo
load-induced bone formation (16), was determined by Western
blot analysis. Primary calvarial cells were subjected to 4 h of
OFF in the absence and presence of E2. Basal COX-2 expres-
sion levels in WT cells were 1.7-fold that of BERKO cells
regardless of treatment with E2 (Fig. 2). COX-2 expression
levels were 2.3-fold greater in WT  VEH cells subjected to
OFF, a significant increase compared with static controls (Fig.
2B). In BERKO  VEH cells subjected to OFF, no significant
increase in COX-2 expression was detected compared with
BERKO  VEH cells kept in static conditions. However, in
the presence of E2 (BERKO  E2), OFF resulted in a signif-
icant, 5.9-fold increase in COX-2 expression (Fig. 2B).
OFF-induced PGE2 release is greatest in BERKO cells in
the presence of E2. PGE2 is an important factor in load-induced
bone formation. Therefore, we analyzed PGE2 release in WT
and BERKO cells in response to OFF. To assess ligand-
independent and ligand-dependent effects of ER in PGE2
release, WT and BERKO cells were subjected to 4 h of OFF in
the absence and presence of E2, and the amount of soluble
PGE2 released 1 h postflow was determined. PGE2 values for
WT  VEH and WT  E2 cells subjected to OFF was
3.5-fold and 3.1-fold that of static controls, respectively,
with absolute values of 24.9 and 29.2 ng/mg of protein (Fig. 3).
BERKO VEH and BERKO E2 cells exhibited a5.6-fold
Fig. 1. ERK phosphorylation in primary wild-type (WT) and estrogen receptor
(ER)-knockout (BERKO) calvarial cells. A: Western blot analysis of anti-
ERK phosphorylation (p-ERK; Y site) and ERK in WT and BERKO cells
exposed to static conditions (S) or 30 min of oscillatory fluid flow (OFF) (F)
in the absence (VEH) and presence of estradiol (E2). Representative bands
from experimental groups are shown. Bands taken from noncontiguous lanes
are divided by black lines. B: quantification of p-ERK/ERK densitometric
ratios, normalized by the mean of p-ERK/ERK for the WT S VEH group (thus
shown as “1”), is presented. Experimental groups contain 2–3 samples. Bars
represent normalized means 
 SE. Genotype, F, and E2 were not significant
factors by a 3-way ANOVA; however, WT VEH F was significantly greater
than WT  VEH S when compared using a Student t-test. aP 	 0.05 vs. WT 
VEH S.
Fig. 2. Expression of cyclooxygenase (COX-2) in primary WT and BERKO
calvarial osteoblasts. A: Western blot analysis of anti-COX-2 and anti-vinculin
(Vinc) in wild-type and BERKO cells exposed to S or 4 h of F in the absence
(VEH) and presence of E2. Representative examples are shown. B: quantifi-
cation of COX-2/Vinc densitometric ratios in WT and BERKO cells. Exper-
iment was performed in triplicate. Bars represent means
 SE. Genotype (P	
0.001), F (P 	 0.0001), and E2 (P 	 0.01) had significant main factor effects
by a 3-way ANOVA. aP 	 0.01 vs. WT  VEH S; bP 	 0.001 vs. WT  E2
S; cP	 0.01 vs. BERKO E2 S; eP	 0.05 vs. BERKO VEH F by Fisher’s
protected least significant difference (PLSD) post hoc analysis.
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and 5.0-fold increase, respectively, in PGE2 in response to
OFF; however, total PGE2 released was significantly greater in
BERKO  E2 cells subjected to OFF (47.4 ng/mg protein)
when compared with all other groups, both static and OFF.
That WT and BERKO cells subjected to OFF exhibit similar
levels of PGE2 in the absence of E2 suggests that ER has no
ligand-independent effect on flow-induced PGE2 release. Con-
versely, the robust PGE2 release in BERKO  E2 cells sub-
jected to OFF indicates that ligand-dependent signaling via
ER normally suppresses flow-induced PGE2 release in osteo-
blasts.
BERKO osteoblasts exhibit greater ER expression and
enhanced cytoplasmic and nuclear localization. Activation of
ERs typically involves receptor translocation to the nucleus,
where it binds to the ERE, activating ERE-driven gene tran-
scription. Thus, we next determined the role of ER in ER
cellular localization in response to OFF. WT and BERKO
calvarial cells were exposed to 1 h of OFF in the absence and
presence of E2, fixed, and stained for ER and DAPI. By
immunofluorescence, we observed that in WT cells exposed to
static conditions in the absence of E2 (WT  VEH), ER was
localized primarily in the nucleus, with punctate cell-cell
junction and cytoplasmic staining also observed (Fig. 4A). One
hour of OFF appeared to slightly enhance nuclear staining in
WT  VEH cells with less membrane staining, indicating a
possible ER translocation from cell-cell junctions to the
nucleus (Fig. 4B). E2 treatment also appeared to increase
nuclear staining, whereas the combination of OFF and E2 did
not further enhance ER nuclear localization. In BERKO 
VEH cells exposed to static conditions, there was robust
cytoplasmic and nuclear ER staining compared with control
cells (Fig. 4C). Both OFF and E2 appeared to similarly enhance
intracellular ER staining, with very little additional enhance-
ment in BERKO cells exposed to the combination of OFF and
E2 (Fig. 4, C and D). These data suggest that ER may
normally help localize ER to the cell membrane, and in the
absence of ER there is cytoplasmic and nuclear translocation.
Basal and flow-induced ER transcriptional activity in-
creased in BERKO osteoblasts in the presence or absence of
ligand. To determine whether enhanced ER intracellular and
nuclear localization observed in BERKO cells translates into
changes in transcriptional activity, WT and BERKO cells were
cotransfected with an ERE-driven luciferase reporter construct
and exposed to static conditions or 12 h of OFF in the absence
and presence of E2. A small and insignificant increase in
relative luciferase activity was observed in both WT and
BERKO cells in the absence of E2 (Fig. 5). Interestingly, ERE
luciferase activity in BERKO cells under both static and flow
conditions was significantly greater than activity observed in
control cells (P 	 0.05, P 	 0.01). E2 treatment also resulted
in a small and insignificant increase in luciferase activity in
WT cells, but the combination of E2 and OFF did not further
increase activity (Fig. 5). E2 treatment alone did not result in
increased activity in BERKO cells; however, OFF did lead to
significantly greater activity in BERKO  E2 cells compared
with BERKO  E2 static controls. Again, both basal and
OFF-induced luciferase activities were significantly increased
in BERKO cells compared with controls in the presence of E2.
Thus, the increased ER localization to the cytoplasm and
nucleus in BERKO cells corresponds with greater ERE activity
observed in these cells, suggesting that ER normally inhibits
ER transcriptional activity.
DISCUSSION
ER plays a significant role in regulating important cellular
mechanotransduction events of ERK phosphorylation, COX-2
upregulation, and PGE2 release. We show that BERKO cells
exhibit higher levels of ER expression, an increase in ER
transcriptional activity, and flow- and ligand-induced PGE2
release.
Important mechanical signaling events in osteoblasts include
activation of the MAPK pathway, an increase in COX-2
expression, and release of prostaglandins. Phosphorylation of
ERK, a member of the MAPK family, peaks within the first 15
min after application of fluid flow shear stress in osteoblasts
and endothelial cells (50, 53) and, as mentioned previously, is
known to be important in cell proliferation, differentiation, and
apoptosis. COX-2 is an important enzyme in the conversion of
arachidonic acid into prostaglandins. In vitro, COX-2 mRNA
and protein levels increase in response to fluid flow shear
stress, making it an important indicator of mechanotransduc-
tion in osteoblasts (3, 39). Prostaglandins are lipid mediators
that are involved in the inflammatory response (38). PGE2 is
the most abundant prostaglandin in the human body, with
known anabolic effects in bone (49). Significant increases in
cellular production of PGE2 in response to fluid flow shear
stress have been shown to affect TGF release, an important
mediator of bone remodeling (24, 40).
Recent data suggest that ER and ER can regulate me-
chanical signaling in bone, and ER itself or signaling via ER
may normally oppose ER in osteoblasts. Adult female
BERKO mice have increased trabecular bone volume (46),
Fig. 3. Prostaglandin E2 (PGE2) release from primary WT and BERKO
calvarial osteoblasts. PGE2 release normalized to total protein in WT and
BERKO cells exposed to S or 4 h of F in the absence (VEH) and presence of
E2. Each group was comprised of 4–7 replicates. Bars represent means 
 SE.
Genotype (P 	 0.05), F (P 	 0.0001), E2 (P 	 0.01), and genotype  F (P 	
0.05) had significant main factor effects by a 3-way ANOVA. aP 	 0.01 vs.
WT  VEH S; bP 	 0.0001 vs. BERKO  VEH S; cP 	 0.001 vs. WT  E2
S; dP 	 0.0001 vs. BERKO  E2; eP 	 0.0001 vs. all other S and F groups
by Fisher’s PLSD post hoc analysis.
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significantly higher cortical bone content and periosteal cir-
cumference (23), and enhanced load-induced bone formation
(43), indicating that ER negatively regulates radial bone
apposition during growth and in response to mechanical stim-
uli.
Our results indicate that ER can regulate signaling path-
ways shown to be important in mechanical signaling in osteo-
blasts, including ERK phosphorylation, COX-2 expression,
PGE2 release, and ER localization. Of these, only PGE2
release appears to be affected by ligand-dependent ER sig-
naling. BERKO cells exhibit reduced OFF-induced ERK phos-
phorylation compared with WT cells in the absence of E2.
Because ERK phosphorylation is involved in increased cell
proliferation and differentiation (52), this result suggests that
ER may be important for osteoblast proliferation in response
to mechanical stimuli in the absence of ligand. This hypothesis
is in contrast to previously published data showing that primary
osteoblasts isolated from female BERKO mice exhibit greater
proliferation rates in response to mechanical strain compared
with WT cells in vitro (125 vs. 61%) (29), suggesting that ER
is antiproliferative. In fact, other studies have shown that ER
can directly inhibit ER-mediated cyclin D1 gene activation, a
key regulator for entry into the proliferative stage of the cell
cycle (31). Although we did not assess flow-induced prolifer-
ation in this study, we did not observe significant differences in
basal growth rate in BERKO cells by both manual counts and
a biochemical assay (data not shown). The means of mechan-
ical stimulation used in the two studies (strain vs. OFF) could
explain these conflicting data. This result is not in agreement
with in vivo data in female BERKO mice. That is, if ERK
phosphorylation played a direct role in the enhanced load-
induced bone formation observed in female BERKO mice,
then p-ERK levels would be greatest in BERKO  E2 cells.
The fact that p-ERK levels appear to be similar in BERKO 
E2 cells compared with WT  E2 suggests that mechanisms
other than ERK phosphorylation are important in enhanced
load-induced bone formation in BERKO mice.
COX-2 is an important enzyme in the conversion of arachi-
donic acid into prostaglandins (7, 11, 39). In vitro, COX-2
mRNA and protein levels increase in response to fluid flow
shear stress (3). In addition, selective inhibition of COX-2
effectively blocks flow-induced PGE2 release in vitro (9) and
load-induced bone formation in vivo (10). That there is an
increase in flow-induced COX-2 expression in WT but not
BERKO cells in the absence of E2 suggests that ER is
normally permissive of flow-induced COX-2 expression in a
ligand-independent manner. Furthermore, the concomitant in-
crease in both COX-2 protein and PGE2 release in WT but not
BERKO cells suggests that sustained COX-2 synthesis is not
necessary for PGE2 release in BERKO cells (Figs. 2 and 3).
We have not ruled out the possibility that COX-2 expression
was upregulated at an earlier time point and then decreased
Fig. 4. Expression of ER in WT and BERKO primary
calvarial cells exposed to static conditions or 1 h of OFF
in the absence (VEH) and presence of E2. Following 1
h of OFF, cells were fixed and stained with anti-ER
antibody, FITC-conjugated secondary antibody, and
DAPI for visualization of ER localization. ER
(FITC) and DAPI images are presented side by side.
A: WT cells treated with VEH or E2 and exposed to
static conditions. B: WT cells treated with VEH or E2
and exposed to 1 h of OFF. C: BERKO cells treated
with VEH or E2 and exposed to static conditions.
D: BERKO cells treated with VEH or E2 and exposed to
1 h of OFF. Images illustrate representative ER local-
ization for each experimental group. Magnification,
400. E: quantification of ER expression in WT and
BERKO cells. Expression of ER is significantly
greater in BERKO vs. WT cells by a Student t-test. aP	
0.05 vs. WT cells.
E941ER REGULATES MECHANICAL SIGNALING
AJP-Endocrinol Metab • doi:10.1152/ajpendo.00458.2013 • www.ajpendo.org
 by 10.220.33.1 on Decem
ber 22, 2016
http://ajpendo.physiology.org/
D
ow
nloaded from
 
over the course of the 4-h flow, which could alternatively
account for the increased PGE2 release. Thus, the COX-2 and
PGE2 data taken together suggest that, in the absence of ligand,
the magnitude of the COX-2 and PGE2 responses is not tightly
coupled in BERKO cells. Further studies are needed to deter-
mine whether ER regulates the relationship between COX-2
expression and PGE2 release.
BERKO  E2 cells showed significantly greater PGE2
release when compared with all other experimental groups.
PGE2 is a known anabolic agent whose increased cellular
production may result in greater osteogenic activity. In vivo
administration of PGE2 to young rats results in increased
trabecular bone volume and greater proliferation and differen-
tiation of progenitors in the marrow (51). Treatment of rat
calvarial osteoblasts with PGE2 results in a dose-dependent
increase in the osteoblast differentiation markers, alkaline
phosphatase activity, and mineralized bone nodule formation
(22). Enhanced PGE2 release observed in BERKO cells may
provide a mechanism for enhanced load-induced bone forma-
tion observed in female BERKO mice.
ERs are localized mainly in the cellular membrane and
nucleus, with some cytoplasmic localization (32). Upon ligand
binding, ERs form homo- or heterodimers and translocate to
the nucleus, where they affect gene transcription. We observed
significantly greater ER expression in BERKO cells, an
observation supported by data showing that ER causes a
significant increase in ligand-dependent ER degradation in
T47D human breast carcinoma cells within 3 h of E2 treatment
(33). We also observed greater cell-cell junction localization of
ER in WT cells, suggesting that ER may normally affect the
subcellular localization of ER. The mechanism by which
subpopulations of estrogen receptors localize to the membrane
is unclear, and further studies are needed to address the
possibility that ER is involved in membrane localization of
ER.
The overall increase in ERE luciferase reporter activity in
BERKO cells supports the observed increased nuclear ER
localization (Fig. 5). Additionally, these studies confirm sig-
nificantly increased ER transcriptional activity in response to
flow in BERKO cells, a phenomenon we did not observe in
WT cells. These data are in agreement with studies showing
that ER can negatively regulate estrogen-mediated transcrip-
tional activity in bone. Microarray analysis of estrogen-medi-
ated gene expression in the humerus of ovariectomized
BERKO mice was shown to be 85% higher compared with WT
controls (30). Animal data are supported by studies showing a
negative regulatory role for ER in human bone metabolism.
Japanese postmenopausal women who harbored one or two
alleles of a specific ER gene polymorphism had significantly
higher lumbar bone mineral density compared with control
subjects not possessing the polymorphism (34). The mecha-
nism of action on bone mineral density is unclear, but the
Ogawa et al. (35) have suggested that the polymorphism may
lead to changes in ER protein function, which could affect the
action of E2 on bone. Taken together, these data suggest that
ER normally acts to negatively regulate ER transcriptional
activity. It is clear that ER plays an important role in bones’
response to mechanical loading. In addition, ER appears to
also be required for Wnt/-catenin signaling (2). Galea et al.
(18) showed that flow activated nuclear accumulation of
-catenin and activated the TCF/LEF promoter in ROS 17/2.8
cells. This response was inhibited by treatment with the ER
modulator ICI-182,780 and the GSK-3 inhibitor lithium chlo-
ride. In addition, this response was not observed in ER/
mice, suggesting that ER is required for Wnt/-catenin sig-
naling in response to mechanical loading. More recently, the
same group showed that both strain and estrogen work through
ER to downregulate Sost expression (18), a gene that inhibits
Wnt signaling and attenuates osteoblast bone formation. Thus,
Wnt signaling can be regulated by both ER and ER. If the
loss of ER results in upregulation of ER, then it may also
enhance Wnt/-catenin signaling, providing another mecha-
nism by which BERKO mice exhibit enhanced mechanical
adaptation.
One interesting observation that should be addressed is the
fact that E2 treatment did not activate ERE activity. One
possible explanation for this is that endogenous ER expression
in osteoblasts is low (15), potentially resulting in relatively low
ERE activity levels. In a separate experiment, we showed that
ERE activity increased in a time-dependent manner only after
cells were transfected with ERs (data not shown). This re-
sponse increased significantly after 12 h of treatment. Keeping
in mind that BERKO cells appear to have greater ER expres-
sion, it is curious they did not exhibit increased ERE activity
with E2 treatment when they clearly exhibited greater basal
ERE activity relative to WT cells. One possible explanation for
this observation is that the effect of E2 and OFF may require
different treatment periods before significant changes in ERE
activity transpire. Zaman et al. (56) showed that, in osteocytes,
strain and estrogen resulted in transient changes in ERmRNA
levels; however, the effects of strain were larger and occurred
earlier than those associated with estrogen treatment. They also
Fig. 5. Relative (firefly/Renilla) luciferase activity in WT and BERKO primary
calvarial cells. Cells were cotransfected with an estrogen response element
luciferase (firefly) reporter plasmid and a control thymidine kinase-driven
Renilla luciferase vector plasmid, treated with VEH or E2, and subjected to
static conditions or 12 h of OFF. Each group was comprised of 3–4 replicates.
Bars represent means 
 SE. Genotype (P 	 0.001) and OFF (P 	 0.05) had
significant main factor effects by a 3-way ANOVA. E2 treatment had no
significant effect. aP 	 0.05 vs. WT  VEH S; bP 	 0.01 vs. WT  VEH F;
cP	 0.05 vs. WT E2 S; dP	 0.001 vs. WT E2 F; eP	 0.05 vs. BERKO
E2 S by Fisher’s PLSD post hoc analysis.
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showed that 36 h of E2 treatment, at similar doses used in the
current study, resulted in a significant increase in ERE-CAT
reporter gene activity in ROS.SMER no. 14 cells, with less of
an effect observed at 18 h (55), suggesting that our 12-h
treatment period may have been too short to allow significant
accumulation of the ERE luciferase product.
The aim of this work was to determine the mechanisms by
which ER regulates mechanical signaling in bone. We ob-
served a suppression of OFF-induced increases in BERKO
cells in the absence of ligand of both ERK and COX-2, two
molecules associated with load-induced increases in bone for-
mation, suggesting that a different mechanism may be at play.
Increased expression and transcriptional activity of ER in
BERKO cells is perhaps the means by which enhancement of
load-induced bone formation occurs. Additionally, we ob-
served no difference in the ability of BERKO cells to release
PGE2 in response to flow in the absence of E2, and in fact, we
observed a synergistic effect of flow and E2. Considering the
importance of prostaglandins in load-induced bone formation,
this result could explain increased bone formation observed in
BERKO mice. Both ER and ER can regulate mechanical
signaling in bone and influence bone adaptation, and in target-
ing ERs (e.g., inhibiting ER), it may represent an effective
approach for prevention and treatment of age-related bone loss.
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